“…Other than the compounds explained above, 5,10-bis(4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-5,10-dihydrophenazine (DHPZ-2TRZ) was known [31], and the solution-processed 2,4,6-tris(4-(9 H-[9,3 :6 , 9 -tercarbazol]-9 -yl)phenyl)-1,3,5-triazine (G2TAZ), 2, 4,6-tris(4-(6 ,6 -di(9H-carbazol-9-yl)-9 H-[9,3 :9 ,3 : 6 ,9 :3 ,9 -quinquecarbazol]-9 -yl)phenyl)-1,3,5-triazine (G3TAZ), and G4TAZ emitters were also described [50]. In spite of the various design approaches, the EQE of the triazine compounds could not reach 20%, but the development of 9-(4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-N3,N3,N6,N6-tetraphenyl-9H-carbazole-3,6-diamine (DACT-II) compound resolved the low EQE issue of the triazine compounds [51]. A diphenylaminocarbazole donor was the key to solving the problem by enabling 100% PLQY and 100% up-conversion efficiency with the help of the close to 0 eV E ST and the dipole orientation of the emitter.…”